Uniting 70+ leaders across Pricing & Reimbursement, Market Access, Marketing Commercial, Government Affairs, Policy, Real-World Evidence, and HEOR domains, this year’s summit provided actional insights for all attendees, whether they were looking to establish a market access department, launch successfully, or bolster the commercial performance of in-market therapies.
